BioSpace News Archive

Urovant Sciences has been busy the past few weeks. In March the company initiated a Phase III trial for an overactive bladder treatment, strengthened its management team and established a U.S. headquarters in Irvine, California.

Intec Pharma LTD (NASDAQ, TASE: NTEC) (“Intec” or “the Company”) today announces that data collected from two Phase 1 studies of its proprietary Accordion Pill Carbidopa/Levodopa (AP-CD/LD) for Parkinson’s disease were highlighted in a poster presentation at the American Academy of Neurology 2018 Annual Meeting (AAN 2018) underway in Los Angeles

Patisiran Reduced the Composite Rate of All-Cause Hospitalization and Mortality by Approximately 50 Percent, Relative to Placebo

Company is targeting upstream aspects of native protein degradation pathways to develop new therapies for cancer

Announces Key Additions to Board of Directors and Senior Management

A new report by A.T. Kearney and RapidRatings shows that supply chain risk management has climbed in priority among most companies, based on current geopolitical volatility.

Freenome’s platform is poised to detect cancer at its earliest stages and help clinicians optimize the next generation of precision therapies.

PHOENIX Rehabilitation and Health Services, Inc. announces the appointment of Joseph P. DiRenzo, MBA as Chief Financial Officer.

Sales of $8.3 billion, up 7.7 percent year-on-year

Puration, Inc. announced finalizing the terms with a Canadian cannabis grow operator for the acquisition of a business intended to expand an existing medical marijuana grow operation in Canada.